🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesHas anyone dealt with coronary artery calcium score changes on glp-1? Page 6

Has anyone dealt with coronary artery calcium score changes on glp-1?

KarenAZ_mom Thu, Apr 4, 2024 at 11:16 PM 35 replies 2,233 viewsPage 6 of 7
BethLabQueen
Senior Member
1,234
5,678
May 2024
Virginia
Online
Apr 8, 2024 at 11:40 PM#26
newstart_MO said:
wendy_avl said: ...cardiovascular risk is just another fad...

I'm 62 years old and want to share my perspective on cardiovascular risk as an older member of this community.

My doctor was initially hesitant because of my age, but the SELECT trial included patients up to 72 and showed consistent benefit across age groups. We started at the lowest dose with closer monitoring.

9 months later: down 36 lbs, off metoprolol, A1C from 7.2% to 5.3%. My cardiologist is thrilled. cardiovascular risk is absolutely relevant for older adults — don't let anyone tell you otherwise.

21 19maya_sedona, stefan_berlin, Dr.EM_Chicago and 18 others
Reply Quote Save Share Report
maria_elpaso
Member
312
1,456
Sep 2024
El Paso, TX
Apr 9, 2024 at 10:22 AM#27

One thing that is still open after newstart_MO’s answer:

How long did you give it before you decided it was working?

Last edited: Apr 9, 2024 at 4:22 PM
22 20RunnerRach, TrialNerd_Beth, HPLC_Greg and 19 others
Reply Quote Save Share Report
tane_welly
Member
234
1,123
Sep 2024
Wellington, NZ
Apr 9, 2024 at 9:04 PM#28
BethLabQueen said:
I'm 62 years old and want to share my perspective on cardiovascular risk as an older member of this community.
BethLabQueen said:
...we're creating a generation dependent on cardiovascular risk...

I understand the concern, but consider this analogy: are we "creating a generation dependent on" blood pressure medication? Cholesterol medication? Thyroid medication?

Obesity is a chronic disease with biological drivers. Treating it with medication is no different from treating any other chronic condition. The "dependency" framing implies weakness or moral failure — neither of which is accurate.

If ongoing medication is what keeps someone healthy, that's successful treatment, not dependency.

Last edited: Apr 10, 2024 at 12:04 AM
23 21DanielChem_CHI, marco_milano, pam_columbus and 20 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
NeuroNate
Senior Member
2,890
16,789
Dec 2023
Chicago, IL
Apr 10, 2024 at 7:46 AM#29
BethLabQueen said:
I'm 62 years old and want to share my perspective on cardiovascular risk as an older member of this community.

SUSTAIN-6 was the first CVOT to show cardiovascular benefit with semaglutide, relevant to cardiovascular risk. In 3,297 T2DM patients with high CV risk: MACE HR 0.74 (95% CI 0.58-0.95, p=0.02)[1].

Notable: the retinopathy signal in SUSTAIN-6 (HR 1.76) was subsequently attributed to rapid A1C reduction in patients with pre-existing retinopathy — not a direct drug effect. This has been confirmed in longer-term follow-up studies.

References:
[1] Marso SP, et al. N Engl J Med. 2016;375(19):1834-1844.
24 22kim_atl_prep, sarah_TO, wendy_avl and 21 others
Reply Quote Save Share Report
KarenAZ_mom
Member
567
2,567
Aug 2024
Scottsdale, AZ
Apr 10, 2024 at 6:28 PM#30
tane_welly said:
BethLabQueen said: ...we're creating a generation dependent on cardiovascular risk...

Dizziness and cardiovascular risk: I was lightheaded for the first 2 weeks. Root cause was a combination of reduced caloric intake and mild dehydration.

Fix: minimum 80-100oz water daily, don't skip meals even if you're not hungry (eat small protein-rich snacks), and stand up slowly from sitting/lying positions. Also check your blood pressure — GLP-1-induced weight loss can make BP meds too strong, requiring dose reduction.

46 19HPLC_Greg, LibrarianMeg, bri_stats and 43 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register